Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial.

Tomasik J, Yolken RH, Bahn S, Dickerson FB.

Biomark Insights. 2015 Jun 1;10:47-54. doi: 10.4137/BMI.S22007. eCollection 2015.

2.

Factors influencing implementation of smoking cessation treatment within community mental health centers.

Brown CH, Medoff D, Dickerson FB, Fang LJ, Lucksted A, Goldberg RW, Kreyenbuhl J, Himelhoch S, Dixon LB.

J Dual Diagn. 2015;11(2):145-50. doi: 10.1080/15504263.2015.1025025.

PMID:
25985201
3.

Metagenomic Sequencing Indicates That the Oropharyngeal Phageome of Individuals With Schizophrenia Differs From That of Controls.

Yolken RH, Severance EG, Sabunciyan S, Gressitt KL, Chen O, Stallings C, Origoni A, Katsafanas E, Schweinfurth LA, Savage CL, Banis M, Khushalani S, Dickerson FB.

Schizophr Bull. 2015 Feb 9. pii: sbu197. [Epub ahead of print]

PMID:
25666826
4.

Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial.

Dickerson FB, Stallings C, Origoni A, Katsafanas E, Savage CL, Schweinfurth LA, Goga J, Khushalani S, Yolken RH.

Prim Care Companion CNS Disord. 2014;16(1). pii: PCC.13m01579. doi: 10.4088/PCC.13m01579. Epub 2014 Feb 13.

5.

Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia.

Koola MM, Buchanan RW, Pillai A, Aitchison KJ, Weinberger DR, Aaronson ST, Dickerson FB.

Schizophr Res. 2014 Aug;157(1-3):84-9. doi: 10.1016/j.schres.2014.04.037. Epub 2014 May 28. Review.

PMID:
24878431
6.

Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder.

Severance EG, Gressitt KL, Yang S, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Alaedini A, Dickerson FB, Yolken RH.

Bipolar Disord. 2014 May;16(3):230-40. doi: 10.1111/bdi.12159. Epub 2013 Dec 6.

7.

Cigarette Smoking and Health Characteristics in Individuals With Serious Mental Illness Enrolled in a Behavioral Weight Loss Trial.

Dickerson FB, Yu A, Dalcin A, Jerome GJ, Gennusa JV 3rd, Charleston J, Crum RM, Campbell L, Oefinger M, Appel LJ, Daumit GL.

J Dual Diagn. 2013 Jan 1;9(1):39-46.

8.

Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Kelly DL, Wehring HJ, Earl AK, Sullivan KM, Dickerson FB, Feldman S, McMahon RP, Buchanan RW, Warfel D, Keller WR, Fischer BA, Shim JC.

BMC Psychiatry. 2013 Aug 22;13:214. doi: 10.1186/1471-244X-13-214.

9.

Exposure to herpes simplex virus, type 1 and reduced cognitive function.

Thomas P, Bhatia T, Gauba D, Wood J, Long C, Prasad K, Dickerson FB, Gur RE, Gur RC, Yolken RH, Nimgaonkar VL, Deshpande SN.

J Psychiatr Res. 2013 Nov;47(11):1680-5. doi: 10.1016/j.jpsychires.2013.07.010. Epub 2013 Aug 3.

10.

Racial patterns of cardiovascular disease risk factors in serious mental illness and the overall U.S. population.

Keenan TE, Yu A, Cooper LA, Appel LJ, Guallar E, Gennusa JV 3rd, Dickerson FB, Crum RM, Anderson CA, Campbell LM, Young DR, Daumit GL.

Schizophr Res. 2013 Oct;150(1):211-6. doi: 10.1016/j.schres.2013.07.022. Epub 2013 Jul 31.

11.

Weight loss in persons with serious mental illness.

Daumit GL, Dickerson FB, Appel LJ.

N Engl J Med. 2013 Aug 1;369(5):486-7. doi: 10.1056/NEJMc1306994. No abstract available.

12.

Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.

Severance EG, Gressitt KL, Stallings CR, Origoni AE, Khushalani S, Leweke FM, Dickerson FB, Yolken RH.

Schizophr Res. 2013 Aug;148(1-3):130-7. doi: 10.1016/j.schres.2013.05.018. Epub 2013 Jun 6.

13.

A behavioral weight-loss intervention in persons with serious mental illness.

Daumit GL, Dickerson FB, Wang NY, Dalcin A, Jerome GJ, Anderson CA, Young DR, Frick KD, Yu A, Gennusa JV 3rd, Oefinger M, Crum RM, Charleston J, Casagrande SS, Guallar E, Goldberg RW, Campbell LM, Appel LJ.

N Engl J Med. 2013 Apr 25;368(17):1594-602. doi: 10.1056/NEJMoa1214530. Epub 2013 Mar 21.

14.

Sociodemographic and clinical features of bipolar disorder patients misdiagnosed with major depressive disorder in China.

Xiang YT, Zhang L, Wang G, Hu C, Ungvari GS, Dickerson FB, Kilbourne AM, Si TM, Fang YR, Lu Z, Yang HC, Lai KY, Lee EH, Hu J, Chen ZY, Huang Y, Sun J, Wang XP, Li HC, Zhang JB, Chiu HF.

Bipolar Disord. 2013 Mar;15(2):199-205. doi: 10.1111/bdi.12052.

PMID:
23437963
15.

Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia.

Severance EG, Gressitt KL, Halling M, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Alaedini A, Dupont D, Dickerson FB, Yolken RH.

Neurobiol Dis. 2012 Dec;48(3):447-53. doi: 10.1016/j.nbd.2012.07.005. Epub 2012 Jul 16.

16.

Use of first- and second-generation antipsychotic medications in older patients with schizophrenia in Asia (2001-2009).

Xiang YT, Kreyenbuhl J, Dickerson FB, Ungvari GS, Wang CY, Si TM, Lee EH, He YL, Chiu HF, Yang SY, Chong MY, Tan CH, Kua EH, Fujii S, Sim K, Yong MK, Trivedi JK, Chung EK, Udomratn P, Chee KY, Sartorius N, Shinfuku N.

Aust N Z J Psychiatry. 2012 Dec;46(12):1159-64. doi: 10.1177/0004867412453625. Epub 2012 Jul 11.

PMID:
22790175
17.

Antipsychotic treatment in older schizophrenia patients with extrapyramidal side effects in Asia (2001 - 2009).

Xiang YT, Kreyenbuhl J, Dickerson FB, Ungvari GS, Wang CY, Si TM, Lee EH, Chiu HF, Lai KY, He YL, Yang SY, Chong MY, Tan CH, Kua EH, Fujii S, Sim K, Yong MK, Trivedi JK, Chung EK, Udomratn P, Chee KY, Sartorius N, Shinfuku N.

Int J Clin Pharmacol Ther. 2012 Jul;50(7):500-4. doi: 10.5414/CP201683.

PMID:
22541750
18.

Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia.

Prasad KM, Watson AM, Dickerson FB, Yolken RH, Nimgaonkar VL.

Schizophr Bull. 2012 Nov;38(6):1137-48. doi: 10.1093/schbul/sbs046. Epub 2012 Apr 6. Review.

19.

Gastrointestinal inflammation and associated immune activation in schizophrenia.

Severance EG, Alaedini A, Yang S, Halling M, Gressitt KL, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Leweke FM, Dickerson FB, Yolken RH.

Schizophr Res. 2012 Jun;138(1):48-53. doi: 10.1016/j.schres.2012.02.025. Epub 2012 Mar 24.

20.

Screening for bipolar disorder with the Mood Disorders Questionnaire in patients diagnosed as major depressive disorder - the experience in China.

Hu C, Xiang YT, Wang G, Ungvari GS, Dickerson FB, Kilbourne AM, Lai KY, Si TM, Fang YR, Lu Z, Yang HC, Hu J, Chen ZY, Huang Y, Sun J, Wang XP, Li HC, Zhang JB, Chiu HF.

J Affect Disord. 2012 Dec 1;141(1):40-6. doi: 10.1016/j.jad.2012.02.035. Epub 2012 Mar 19.

PMID:
22436092
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk